Harold Davidson & Associates’s Eli Lilly LLY Stock Holding History

Harold Davidson & Associates’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$5.48M	Sell	4,737 -30	-0.6%	-$35.4K	2.22%	11
2026 Q2	$5.72M	Buy	4,767 +97	+2%	+$99.1K	2.48%	10
2026 Q1	$4.3M	Buy	4,670 +13	+0.3%	+$13.2K	2.09%	13
2025 Q4	$5M	Buy	4,657 +58	+1%	+$55.5K	2.21%	12
2025 Q3	$3.51M	Buy	4,599 +1,417	+45%	+$1.05M	1.59%	16
2025 Q2	$2.48M	Sell	3,182 -902	-22%	-$701K	1.61%	15
2025 Q1	$3.37M	Buy	4,084 +42	+1%	+$34.9K	1.84%	14
2024 Q4	$3.12M	Buy	+4,042	New	+$3.35M	1.49%	19

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $104B AUM 51.65% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Bank Julius Baer & Co Zurich, Switzerland $39.3B AUM 31.81% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Old National Bancorp Evansville, Indiana $5.07B AUM 22.07% 1-Year Est. Return

Harold Davidson & Associates's LLY Position: Q3 2026 in Review

Harold Davidson & Associates reduced its Eli Lilly (LLY) stake by 0.63% in Q3 2026, selling an estimated $35.4K and leaving 4,737 shares worth $5.48M. The position accounts for 2.22% of the portfolio, ranked #11.

Harold Davidson & Associates first reported a position in LLY in Q4 2024 and has held it in 8 quarters since. The position peaked at $5.72M in Q2 2026. 2,091 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

Harold Davidson & Associates held 4,737 shares of Eli Lilly worth $5.48M as of Q3 2026.
Harold Davidson & Associates sold 30 Eli Lilly shares in Q3 2026, an estimated $35.4K.
Eli Lilly made up 2.22% of Harold Davidson & Associates's portfolio in Q3 2026, its #11 holding.
Harold Davidson & Associates first reported a position in Eli Lilly in Q4 2024 and has held it in 8 quarters since.
Harold Davidson & Associates's Eli Lilly position peaked at $5.72M in Q2 2026.
2,091 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Harold Davidson & Associates's 13F filing for Q3 2026, filed 29 Oct 2026.